Almoxatone
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
![]() |
|
Systematic (IUPAC) name | |
---|---|
(5R)-3-{4-[(3-chlorobenzyl)oxy]phenyl}-5-[(methylamino)methyl]-1,3-oxazolidin-2-one
|
|
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 84145-89-1 ![]() |
ATC code | none |
PubChem | CID: 172287 |
ChemSpider | 150582 ![]() |
UNII | 85V47MCE4Z ![]() |
ChEMBL | CHEMBL2104006 ![]() |
Chemical data | |
Formula | C18H19ClN2O3 |
Molecular mass | 346.81 g/mol |
|
|
|
|
![]() ![]() |
Almoxatone (MD-780,236) is a selective and reversible inhibitor of MAO-B.[1][2] It was patented as an antidepressant and antiparkinsonian agent but was never marketed.[3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||
|
Dopaminergics |
|
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Anticholinergics | |||||||||||
Others | |||||||||||
|
|||||||||||
|
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
<templatestyles src="Asbox/styles.css"></templatestyles>
Retrieved from "https://infogalactic.com/w/index.php?title=Almoxatone&oldid=5018270"
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Amines
- Antidepressants
- Monoamine oxidase inhibitors
- Oxazolidinones
- Phenol ethers
- Chloroarenes
- Amine stubs